Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07241286

Evaluation of the Effectiveness of Enhanced Recovery After Surgery (ERAS) Program in Pediatric Lung Surgery

This study aims to evaluate the clinical effectiveness of the Enhanced Recovery After Surgery (ERAS) program for pediatric lung surgery at our institution.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Lung Surgery Enhanced Recovery After Surgery, ERAS Pediatric

Age range

0 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, Taiwan

About this study

Using a prospective cohort design, we will observe pediatric patients undergoing lung surgery following the implementation of the ERAS program as standard practice. Outcomes will be compared with a historical control group (2014-2023) to assess whether ERAS reduces hospital length of stay, lowers postoperative complication rates, accelerates recovery, and decreases healthcare costs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children who underwent lung surgery at our hospital's Division of Pediatric Surgery

Exclusion criteria

  • Patients who underwent multiple surgeries (including surgeries other than lung surgery) during the same hospitalization

Treatment and study plan

Enhanced Recovery After Surgery, ERAS

Other

During the study period, all enrolled patients will be managed according to our institution's consensus checklist for pediatric lung surgery ERAS care. This includes ERAS education, preoperative assessment, fasting guidance, prophylaxis for nausea and vomiting, standardized anesthesia and surgical protocols, preference for minimally invasive surgery, multimodal postoperative analgesia, and encouragement of early oral intake and mobilization.

Primary outcomes

  1. Length of hospital stay

    Time frame: Up to 30 days after surgery.

    Number of days from index operation to hospital discharge

Secondary outcomes

  1. Postoperative complications

    Time frame: Within 30 days after surgery.

    Incidence of postoperative complications, including prolonged air leak, pneumonia, surgical site infection, and other procedure-related events.

  2. Duration of urinary catheter placement

    Time frame: From date of surgery to catheter removal (up to 30 days)

    Number of days with indwelling urinary catheter postoperatively.

  3. Duration of chest tube drainage

    Time frame: From date of surgery to chest tube removal (up to 30 days).

    Number of days with thoracic drainage tube postoperatively.

  4. Intensive care unit stay

    Time frame: From date of ICU admission to transfer out (up to 30 days).

    Number of days in ICU after surgery.

  5. Postoperative pain

    Time frame: Daily assessment up to 7 days postoperatively.

    Pain intensity assessed by numeric rating scale (NRS)

  6. Postoperative analgesic use

    Time frame: Daily assessment up to 7 days postoperatively.

    Total analgesic consumption.

  7. 30-day readmission or emergency department visit

    Time frame: Within 30 days post-discharge.

    Incidence of unplanned readmission or emergency department visit within 30 days after discharge.

  8. Time to resumption of oral intake

    Time frame: From date of surgery to initiation of oral intake (up to 7 days).

    Interval from surgery to first tolerated oral feeding.

  9. Hospital cost

    Time frame: From date of admission to discharge, up to 30 days

    Total hospitalization cost during the index admission.

Other outcomes

  1. ERAS protocol adherence rate

    Time frame: Up to 30 days after surgery

    Proportion of ERAS protocol elements implemented per patient compared to total eligible elements.

  2. Patient satisfaction with ERAS program

    Time frame: Up to 30 days after surgery.

    Satisfaction assessed by structured questionnaire at discharge.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2030
Study completion
2030
First posted
Nov 21, 2025
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.